RaQualia Pharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Hirobumi Takeuchi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.7yrs |
| CEO ownership | 0.05% |
| Management average tenure | no data |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
Market Participants Recognise RaQualia Pharma Inc.'s (TSE:4579) Revenues Pushing Shares 27% Higher
Sep 04
With RaQualia Pharma Inc. (TSE:4579) It Looks Like You'll Get What You Pay For
Jul 17Companies Like RaQualia Pharma (TYO:4579) Can Afford To Invest In Growth
Apr 02The RaQualia Pharma (TYO:4579) Share Price Has Soared 410%, Delighting Many Shareholders
Feb 08
Companies Like RaQualia Pharma (TYO:4579) Can Afford To Invest In Growth
Dec 17CEO
Hirobumi Takeuchi (53 yo)
3.7yrs
Tenure
Mr. Hirobumi Takeuchi is President & Chairman of the Board of RaQualia Pharma Inc. from March 2021. He joined the RaQualia Pharma Inc. in March 2021. He served as the Chief Financial Officer at Skylight Bi...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Chairman of the Board | 3.8yrs | no data | 0.052% ¥ 5.2m | |
| Executive Officer & Director | 2.7yrs | no data | 0.078% ¥ 7.8m | |
| VP & Director | 2.7yrs | no data | 0.039% ¥ 3.9m | |
| Independent Outside Director | 3.7yrs | no data | 11.02% ¥ 1.1b | |
| Independent Outside Director | 4.7yrs | no data | no data | |
| Independent Outside Director | 3.8yrs | no data | no data | |
| Independent Outside Director | 3.7yrs | no data | no data |
3.7yrs
Average Tenure
53yo
Average Age
Experienced Board: 4579's board of directors are considered experienced (3.7 years average tenure).